#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neurodevelopmental disorder Solitary fibrous tumour Burkitt's lymphoma refractory Marginal zone lymphoma recurrent Neovascular age-related macular degeneration Bladder cancer Follicular lymphoma Aspergillus infection Anaplastic thyroid cancer CDKL5 deficiency disorder Chronic graft versus host disease in skin Anal squamous cell carcinoma Paraneoplastic neurological syndrome Arterial disorder Breast angiosarcoma More trials…

    Learn about Rare Diseases

    Piriformis syndrome – Life with Disease Congenital hypotransferrinaemia – Treatment Marfan’s syndrome Rett syndrome – Life with Disease Systemic sclerosis pulmonary – Treatment Familial haemophagocytic lymphohistiocytosis – Trials in Disease Uterine leiomyosarcoma – Life with Disease Ornithine transcarbamoylase deficiency – Life with Disease Hereditary angioedema – Basic Information Malignant fibrous histiocytoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Meropenem Anhydrous Calcium Chloride Dihydrate Mk-6194 SEVUPARIN Vibegron Mebeverine Hydrochloride HSP-CAR19M Nifedipine ADS-019 DROSPIRENONE Atropine Sulfate Monohydrate Argipressin Eptinezumab Desoximetasone Namilumab Int-787 Ly3437943 Sodium Bio89-100 Dimethyl Fumarate Crisantaspase More therapies…

    Learn about Your Condition

    Osteosarcoma metastatic Neoplasm Pustular psoriasis Erythema migrans Neutropenia Seizure Pleomorphic leiomyosarcoma Acute kidney injury Rhabdomyosarcoma Glucose tolerance impaired B-cell type acute leukaemia Peripheral ischaemia Colorectal adenocarcinoma Congenital ureteric anomaly Thrombotic microangiopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Med Polonia Sp. z o.o.

Med Polonia Sp. z o.o.

Obornicka 262, Poznan, 60-693, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Olaparib
    Austria Belgium France Germany Hungary Iceland +6

  • Study on the Safety and Tolerability of Spartalizumab for Patients with Advanced Cancer

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • 3-[6-(1-Benzylpiperidin-4-Yl)-3-Oxo-1H-Isoindol-2-Yl]Piperidine-2,6-Dione
    • Canakinumab
    • Capmatinib
    Belgium Czechia France Germany Hungary Italy +2

  • Study of Pembrolizumab, Carboplatin, and Paclitaxel for Patients with Metastatic Squamous Non-small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of lung
    Investigated Drugs:
    • Carboplatin
    • Olaparib
    • Paclitaxel
    Austria France Germany Poland Romania Spain

  • Study of AFM24 and Atezolizumab for Patients with Advanced or Metastatic EGFR-expressing Cancers

    Not recruiting

    1 1 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Afm24
    • Atezolizumab
    • Docetaxel
    Poland Spain

  • Study of Pembrolizumab, Olaparib, and Pemetrexed for Patients with Stage IV Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Olaparib
    Austria France Germany Poland Romania Spain

  • Study on the Effects of EryDex (Dexamethasone Sodium Phosphate) for Children Aged 6-9 with Ataxia Telangiectasia

    Not recruiting

    3 1
    Investigated Diseases:
    • Ataxia telangiectasia
    Investigated Drugs:
    • Dexamethasone Sodium Phosphate
    Belgium Denmark Germany Italy Norway Poland +1

  • Study on the Effects of Inebilizumab for Adults with Myasthenia Gravis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Inebilizumab
    France Germany Italy Poland Spain

  • Study of LY3541860 and Meglumine Gadoterate for Adults with Relapsing Multiple Sclerosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Ly3541860
    • Meglumine Gadoterate
    France Germany Italy Latvia Lithuania Poland +1

  • Study on Vudalimab or Pembrolizumab with Chemotherapy for Advanced Non-small Cell Lung Cancer Patients

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Pembrolizumab
    • Pemetrexed
    Belgium Greece The Netherlands Poland Portugal Romania +1

  • A Study of GEN1047 in Patients with Solid Tumors: First Time Use in Humans

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Gen1047
    Belgium Denmark France Italy The Netherlands Poland +1
Previous Page
1 … 5 6 7 8 9 10
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!